HHS OIG Compiles Drug Pricing Guidances in Online Portfolio

February 28, 2017

FDA News reported that an online portfolio of the U.S. Department of Health and Human Services Office of Inspector General’s (OIG) body of work since 2010 has been published. “The online hub will gather together past and future reports on reimbursement policies, spending trends and data integrity, along with previously published materials on savings from extending rebates to generic drugs.” This information is also used to compare “different payment methodologies across Medicare, Medicaid and 340B programs.”